Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

3.35
-0.0500-1.47%
Pre-market: 3.430.0800+2.39%04:00 EDT
Volume:716.04K
Turnover:2.42M
Market Cap:145.04M
PE:-4.32
High:3.45
Open:3.39
Low:3.32
Close:3.40
52wk High:5.06
52wk Low:1.62
Shares:43.30M
Float Shares:37.42M
Volume Ratio:0.94
T/O Rate:1.91%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7754
EPS(LYR):-1.3374
ROE:-682.61%
ROA:-63.99%
PB:-853.18
PE(LYR):-2.50

Loading ...

FDA completes review of NRx Pharmaceuticals preservative-free ketamine ANDA

TIPRANKS
·
Aug 07

FDA Flags Packaging Certification as Sole Major Deficiency for NRx Preservative-Free Ketamine ANDA Approval

Reuters
·
Aug 07

NRX Pharmaceuticals - FDA Finds no Major Deficiencies in Ketamine Anda First-Cycle Review

THOMSON REUTERS
·
Aug 07

NRX Pharmaceuticals - no New Clinical or Safety Data Required for Ketamine Anda Approval

THOMSON REUTERS
·
Aug 07

NRX Pharmaceuticals - FDA to Review Certification in Shortest Possible Cycle After Aug 6, 2026 Meeting

THOMSON REUTERS
·
Aug 07

FDA Completes First-Cycle Review of Preservative-Free Ketamine Anda with no Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

THOMSON REUTERS
·
Aug 07

NRX Pharmaceuticals - on July 21, Nrxd Selected by Darpa for Negotiation of Potential Sparc-tms Clinical Trial Award - SEC Filing

THOMSON REUTERS
·
Jul 22

Market Sentiment Around Loss-Making NRx Pharmaceuticals, Inc. (NASDAQ:NRXP)

Simply Wall St.
·
Jul 16

Nrx Pharmaceuticals Pushes Kadima Dispute into Arbitration Amid Acquisition Lawsuit

Reuters
·
Jun 26

NRX Pharmaceuticals - Initiates Arbitration with Kadima over Failed Closing Conditions

THOMSON REUTERS
·
Jun 26

NRX Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute

THOMSON REUTERS
·
Jun 26

NRX Pharmaceuticals: Co Does not Believe That Acquisition/non-acquisition of Any Individual Clinic Would be Material to Hope's Overall Business Model

THOMSON REUTERS
·
Jun 26

H.C. Wainwright Keeps Their Buy Rating on NRX Pharmaceuticals (NRXP)

TIPRANKS
·
Jun 25

Nrx Subsidiary HOPE Therapeutics Begins Patient Treatments Using Zeta Surgical TMS Navigation System

Reuters
·
Jun 25

NRX Pharmaceuticals (nasdaq: Nrxp) Subsidiary Hope Therapeutics Treats First Patients Using Zeta Surgical's Fda-cleared Zeta Tms Navigation System

THOMSON REUTERS
·
Jun 25

Kadima Neuropsychiatry Institute alleges NRx breached contract

TIPRANKS
·
Jun 25

Kadima Neuropsychiatry Institute Files Suit Against NRX Pharmaceuticals (nasdaq: Nrxp), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition

THOMSON REUTERS
·
Jun 25

Kadima Neuropsychiatry Institute: Lawsuit Seeks Specific Performance in Court Order Compelling Defendants to Close Deal on Terms in Executed Agreement

THOMSON REUTERS
·
Jun 25

Kadima Neuropsychiatry Institute: Complaint Alleges NRX Warranted it Had Funds to Close While Concealing it Lacked Committed Financing for Deal

THOMSON REUTERS
·
Jun 25

Kadima Neuropsychiatry Institute Sues Nrx Pharma over Alleged Breach, Misrepresentation in Acquisition Deal

Reuters
·
Jun 25